We have qualitatively reviewed this strategy and reaffirmed its Process and People ratings. Vanguard Primecap stands out for its seasoned management and high-conviction multimanager system. The remainder of this analysis is from July 7, 2023.
Vanguard PRIMECAP Inv VPMCX
- NAV / 1-Day Return 175.92 / +0.30 %
- Total Assets 76.1 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.380%
- Distribution Fee Level Low
- Share Class Type No Load
- Category Large Blend
- Investment Style Large Growth
- Min. Initial Investment 3,000
- Status Open
- TTM Yield 0.91%
- Turnover 4%
USD | NAV as of Jul 05, 2024 | 1-Day Return as of Jul 05, 2024, 10:22 PM GMT+0
Morningstar’s Analysis VPMCX
Will VPMCX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 40.2
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Eli Lilly and Co | 12.69 | 9.6 Bil | Healthcare |
Micron Technology Inc | 3.68 | 2.8 Bil | Technology |
Microsoft Corp | 3.42 | 2.6 Bil | Technology |
Amgen Inc | 3.37 | 2.6 Bil | Healthcare |
FedEx Corp | 3.26 | 2.5 Bil | Industrials |
KLA Corp | 3.22 | 2.4 Bil | Technology |
Adobe Inc | 2.85 | 2.2 Bil | Technology |
Intel Corp | 2.69 | 2.0 Bil | Technology |
Biogen Inc | 2.60 | 2.0 Bil | Healthcare |
Texas Instruments Inc | 2.44 | 1.9 Bil | Technology |